Medvalis - Company finances
|
EUR
|
2019
From: 2019-06-10
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 100,025 | 183,734 | 239,854 | 339,724 | 351,913 | 298,481 | 410,099 |
| Profit before tax | 64,251 | 70,629 | 67,398 | 121,167 | 95,139 | 68,144 | 66,085 |
| Net profit | 64,251 | 67,091 | 64,028 | 102,917 | 80,943 | 64,737 | 55,511 |
| Equity | 2,500 | 2,750 | 2,750 | 105,667 | 186,610 | 186,610 | 261,663 |
| Liabilities | 67,674 | 72,423 | 71,023 | 20,689 | 18,281 | 72,394 | 66,084 |
| Non-current assets | 0 | 3,815 | 837 | 5,526 | 4,147 | 14,966 | 34,051 |
| Current assets | 1,933 | 71,358 | 72,809 | 3,170 | 200,744 | 244,038 | 293,696 |
| Total assets | 1,933 | 75,173 | 73,646 | 8,696 | 204,891 | 259,004 | 327,747 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 55,518 | 54,556 | 44,116 |
| Social insurance contributions | - | - | - | - | 44,223 | 35,956 | 47,849 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +83.7% | +30.5% | +41.6% | +3.6% | -15.2% | +37.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3323.9% | 89.2% | 86.9% | 1183.5% | 39.5% | 25.0% | 16.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 2570.0% | 2439.7% | 2328.3% | 97.4% | 43.4% | 34.7% | 21.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 64.2% | 36.5% | 26.7% | 30.3% | 23.0% | 21.7% | 13.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 64.2% | 38.4% | 28.1% | 35.7% | 27.0% | 22.8% | 16.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 27.1 | 26.3 | 25.8 | 0.2 | 0.1 | 0.4 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 18,426 | 22,967 | 29,073 | 35,144 | 31,515 | 36,549 | 45,567 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medvalis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-12-16 | 2021-12-19 | 17.12 |
| 2021-11-16 | 2021-11-28 | 59.74 |
Medvalis - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medvalis, UAB (company code 305187076) is a private limited liability company engaged in repair and renovation of buildings. In 2025, the company generated revenue of €410.1K, up from €298.5K in 2024 and €351.9K in 2023, showing a stronger top-line trend over the latest year and a moderate increase over two years. Net profit was €55.5K in 2025, compared with €64.7K in 2024 and €80.9K in 2023, so profitability remained positive but softened as the year progressed. The profit margin declined to 13.5% in 2025 from 21.7% in 2024 and 23.0% in 2023. At year-end 2025, total assets stood at €327.7K, equity at €261.7K and liabilities at €66.1K. The balance sheet remained solid, with an equity ratio of 79.8% and debt-to-equity of 0.25. Return on equity was 21.2%, return on assets 16.9%, and asset turnover 1.25x. Revenue per employee was €45.6K, while profit per employee was €6.2K.